Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Behavioral Neurology & Neuropsychiatry
How do you distinguish pseudodementia from early Alzheimer's diease with comorbid depression?
Related Questions
How do you approach an isolated increased protein levels in the CSF in patients with cognitive decline?
How does APOE4 status affect your clinical decision-making in patients who may be eligible for anti-amyloid therapies for early Alzheimer's disease?
Do you use amyloid lowering therapy in patients on chronic anticoagulation?
Do you recommend routine neurosyphilis testing in patients being evaluated for dementia?
How do you counsel patients who develop DVT or atrial fibrillation requiring anticoagulation when being treated with lecanemab or donanemab?
What would prompt discontinuing treatment versus switching or sequencing treatment in patients treated with an anti-amyloid therapy for Alzheimer's?
Are there specific tools that you request for an IEP of a child with dyslexia?
How long do you typically wait before starting anticoagulation after holding Leqembi/Kisunla in patients with cognitive impairment?
How do you counsel eligible patients on how to decide between lecanemab vs donanemab?
How do you approach management of neurocognitive and memory deficits in post concussive syndrome?
